These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


520 related items for PubMed ID: 24007408

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Current and emerging treatments for irritable bowel syndrome with constipation and chronic idiopathic constipation: focus on prosecretory agents.
    Thomas RH, Luthin DR.
    Pharmacotherapy; 2015 Jun; 35(6):613-30. PubMed ID: 26016701
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Economic evaluation of linaclotide for the treatment of adult patients with irritable bowel syndrome with constipation in the United States.
    Huang H, Taylor DC, Carson RT, Sarocco P, Friedman M, Munsell M, Blum SI, Menzin J.
    J Med Econ; 2015 Apr; 18(4):283-94. PubMed ID: 25333331
    [Abstract] [Full Text] [Related]

  • 7. The pharmacokinetics, pharmacodynamics, clinical efficacy, safety and tolerability of linaclotide.
    Lee N, Wald A.
    Expert Opin Drug Metab Toxicol; 2011 May; 7(5):651-9. PubMed ID: 21446888
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Linaclotide for irritable bowel syndrome with constipation: a 26-week, randomized, double-blind, placebo-controlled trial to evaluate efficacy and safety.
    Chey WD, Lembo AJ, Lavins BJ, Shiff SJ, Kurtz CB, Currie MG, MacDougall JE, Jia XD, Shao JZ, Fitch DA, Baird MJ, Schneier HA, Johnston JM.
    Am J Gastroenterol; 2012 Nov; 107(11):1702-12. PubMed ID: 22986437
    [Abstract] [Full Text] [Related]

  • 11. Randomised clinical trials: linaclotide phase 3 studies in IBS-C - a prespecified further analysis based on European Medicines Agency-specified endpoints.
    Quigley EM, Tack J, Chey WD, Rao SS, Fortea J, Falques M, Diaz C, Shiff SJ, Currie MG, Johnston JM.
    Aliment Pharmacol Ther; 2013 Jan; 37(1):49-61. PubMed ID: 23116208
    [Abstract] [Full Text] [Related]

  • 12. New treatment targets for the management of irritable bowel syndrome.
    Rao S, Weber HC.
    Curr Opin Endocrinol Diabetes Obes; 2014 Feb; 21(1):9-14. PubMed ID: 24300740
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Linaclotide: a novel agent for chronic constipation and irritable bowel syndrome.
    Love BL, Johnson A, Smith LS.
    Am J Health Syst Pharm; 2014 Jul 01; 71(13):1081-91. PubMed ID: 24939497
    [Abstract] [Full Text] [Related]

  • 16. Linaclotide, a synthetic guanylate cyclase C agonist, for the treatment of functional gastrointestinal disorders associated with constipation.
    Vazquez Roque M, Camilleri M.
    Expert Rev Gastroenterol Hepatol; 2011 Jun 01; 5(3):301-10. PubMed ID: 21651347
    [Abstract] [Full Text] [Related]

  • 17. Linaclotide: a review of its use in the treatment of irritable bowel syndrome with constipation.
    McCormack PL.
    Drugs; 2014 Jan 01; 74(1):53-60. PubMed ID: 24293117
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. [Pharmacological and clinical profile of linaclotide (Linzess®), a novel therapeutic agent for irritable bowel syndrome with constipation and chronic constipation].
    Keto Y, Kosako M.
    Nihon Yakurigaku Zasshi; 2019 Jan 01; 153(6):289-298. PubMed ID: 31178535
    [Abstract] [Full Text] [Related]

  • 20. New pharmacological treatment options for irritable bowel syndrome with constipation.
    Nusrat S, Miner PB.
    Expert Opin Emerg Drugs; 2015 Jan 01; 20(4):625-36. PubMed ID: 26548544
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 26.